SEC Form 4 Reporting Owner · CIK 0001810882
David Lebwohl
EVP at Intellia Therapeutics Inc
Bought (12 mo)
—
Sold (12 mo)
−$110K
Form 4 Filings
19
Companies
1
Filing Activity
2026-03-03
first filed 2021-03-05
Trading record
Open-market buys
—
0 filings
Open-market sales
−$2.37M
10 filings
Sales under a 10b5-1 plan
50%
5 of 10 sale filings · 2 undisclosed
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| NTLAIntellia Therapeutics Insider trading | EVP | 19 | — | 42,928 | −42,928 | 131,192 2026-03-03 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.